Leadership Overview
Cipla has 9 executives leading key functions including strategy, finance, operations, and sales.
Driven by a commitment to global health, Cipla develops, manufactures, and distributes a broad range of pharmaceutical products, addressing critical therapeutic areas and impacting millions worldwide.
Driven by a commitment to global health, Cipla develops, manufactures, and distributes a broad range of pharmaceutical products, addressing critical therapeutic areas and impacting millions worldwide.
Leadership Roles at Cipla
Shivam Goyal - Chief Executive Officer
Shivam Goyal, the Chief Executive Officer at Cipla, directs the company's overarching strategy and global operations. This leadership position involves guiding the development, manufacturing, and distribution of a wide array of generic and branded generic medicines, vaccines, and active pharmaceutical ingredients. Goyal ensures that Cipla's product portfolio effectively addresses critical therapeutic areas, including cardiovascular disease, oncology, and infectious diseases, aligning with the company's mission to provide accessible healthcare solutions. The Chief Executive Officer's role necessitates close collaboration with functional leaders across the organization to drive innovation and maintain market leadership. Shivam Goyal's strategic vision shapes Cipla's expansion into new markets and its commitment to advancing global health outcomes through pharmaceutical excellence.
Upali Seneviratne - MD and Chief Executive Officer
Upali Seneviratne, the MD and Chief Executive Officer at Cipla, spearheads the company's strategic direction and operational execution across its global footprint. This executive leadership role encompasses the comprehensive management of Cipla's Pharmaceuticals and New Ventures segments, driving the development, manufacturing, marketing, and distribution of essential medicines, vaccines, and active pharmaceutical ingredients. Seneviratne focuses on expanding Cipla's reach in key markets such as India, the United States, and South Africa, ensuring the company's broad range of products addresses diverse therapeutic needs, from respiratory and asthma care to oncology and diabetes. The MD and Chief Executive Officer's responsibilities include fostering innovation within the consumer healthcare, biosimilars, and specialty medicine businesses. Upali Seneviratne's leadership ensures Cipla's continued growth as a major global healthcare player.
Marc Falkin - Chief Executive Officer (North America)
Marc Falkin, the Chief Executive Officer (North America) at Cipla, leads the company's strategic development and operational management within the crucial North American market. This executive role is responsible for driving Cipla's growth and expanding its presence by overseeing the marketing, sales, and distribution of its comprehensive range of pharmaceutical products, including generic and branded generics, vaccines, and active pharmaceutical ingredients. Falkin focuses on adapting Cipla's offerings to meet the specific healthcare needs and regulatory landscape of the United States and Canada, addressing therapeutic areas such as cardiovascular disease, oncology, and respiratory conditions. The Chief Executive Officer (North America)'s responsibilities include building strategic partnerships and ensuring operational excellence. Marc Falkin's leadership is pivotal in strengthening Cipla's commitment to making high-quality healthcare accessible in North America.
C.A. Kadam - Chief Financial Officer
C.A. Kadam, the Chief Financial Officer at Cipla, directs the company's financial strategy, planning, and reporting across its global operations. This executive position is integral to managing Cipla's financial health, overseeing budgeting, forecasting, and investment decisions that support the development and distribution of its broad range of pharmaceutical products. Kadam ensures robust financial controls and compliance with regulatory requirements in markets including India, the United States, and South Africa. The Chief Financial Officer's responsibilities extend to optimizing capital allocation, managing risk, and driving financial performance to sustain Cipla's growth in areas such as respiratory care, oncology, and diabetes. C.A. Kadam's financial acumen is essential for Cipla's continued expansion and its commitment to providing affordable healthcare solutions.
Ravi Reddy - Chief Operating Officer
Ravi Reddy, the Chief Operating Officer at Cipla, oversees the company's extensive manufacturing, supply chain, and operational processes across its global network. This leadership role is crucial for ensuring the efficient production and timely distribution of Cipla's diverse pharmaceutical products, including generic and branded generics, vaccines, and active pharmaceutical ingredients. Reddy focuses on optimizing operational efficiency, enhancing quality control, and driving supply chain resilience to meet market demands in India, the United States, South Africa, and other international territories. The Chief Operating Officer's responsibilities include managing production facilities, implementing best practices in manufacturing, and ensuring compliance with stringent regulatory standards. Ravi Reddy's operational expertise supports Cipla's mission to deliver accessible and high-quality healthcare solutions across multiple therapeutic areas.
Vishrut Awasthi - Commercial Excellence Lead - Global Chief Operating Officer Office
Vishrut Awasthi, the Commercial Excellence Lead - Global Chief Operating Officer Office at Cipla, drives initiatives to enhance commercial effectiveness and operational efficiency across the company's global sales and marketing functions. This role focuses on optimizing sales processes, improving customer engagement, and ensuring the successful market introduction and penetration of Cipla's diverse pharmaceutical products. Awasthi collaborates closely with regional sales and marketing teams to implement best practices and leverage data analytics for strategic decision-making, supporting Cipla's mission to deliver accessible healthcare solutions. The Commercial Excellence Lead's responsibilities include developing frameworks for performance management and driving continuous improvement within the commercial operations. Vishrut Awasthi's contributions are key to strengthening Cipla's market position and achieving its business objectives.
Sneha Hiranandani - Chief Information Officer
Sneha Hiranandani, the Chief Information Officer at Cipla, architects and oversees the company's global information technology infrastructure and digital strategy. This critical role ensures the seamless integration of technology across all business functions, supporting the development, manufacturing, and distribution of Cipla's extensive pharmaceutical portfolio. Hiranandani drives initiatives that enhance operational efficiency, data security, and innovation, directly impacting the company's ability to deliver accessible healthcare solutions worldwide. The Chief Information Officer's responsibilities include managing IT operations, cybersecurity measures, and digital transformation projects that align with Cipla's business objectives in areas like cardiovascular disease, HIV/AIDS, and oncology. Sneha Hiranandani's leadership ensures Cipla leverages cutting-edge technology to maintain its competitive edge and expand its market presence.
Sagar Laddha - Chief Sales Officer (CSO)
Sagar Laddha, the Chief Sales Officer (CSO) at Cipla, drives the company's global sales strategy and execution, focusing on expanding market penetration for its broad portfolio of pharmaceutical products. This executive role involves leading sales teams across various regions, including India, the United States, and South Africa, to achieve revenue targets and strengthen Cipla's market presence. Laddha oversees the development and implementation of sales initiatives that effectively promote Cipla's generic and branded generic medicines, vaccines, and active pharmaceutical ingredients across diverse therapeutic areas such as cardiovascular disease, respiratory care, and oncology. The Chief Sales Officer (CSO)'s responsibilities include fostering strong relationships with healthcare providers, distributors, and key stakeholders. Sagar Laddha's sales leadership is instrumental in driving Cipla's commercial success and its mission to make healthcare accessible.
Rohidas Patil - Sr. Executive Chief Marketing Officer Operations
Rohidas Patil, the Sr. Executive Chief Marketing Officer Operations at Cipla, directs the strategic marketing initiatives and operational execution for the company's global pharmaceutical offerings. This leadership position involves overseeing market analysis, brand development, and promotional strategies to enhance Cipla's market share across key therapeutic areas, including HIV/AIDS, respiratory conditions, and oncology. Patil ensures that marketing efforts align with the company's mission to provide accessible healthcare solutions, driving demand for its broad range of generic and branded generic medicines, vaccines, and active pharmaceutical ingredients. The Sr. Executive Chief Marketing Officer Operations' responsibilities include coordinating marketing campaigns across different regions and optimizing operational workflows to support sales objectives. Rohidas Patil's expertise in marketing operations is vital for Cipla's sustained growth and global impact.
Explore Leadership Teams in Manufacturing
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership JV
SP
AM
Founded in 1993 and located in Cambridge, Massachusetts, Takeda Oncology is the oncology specialty business unit of Takeda Pharmaceutical. Takeda Oncology develops and produces oncology therapies for patients around the world.
Company Leadership
TF
CB
Founded in 1969, Themis Medicar is a pharmaceutical company that specializes in manufacturing pharmaceuticals and medicinal chemicals for cardiology, pain management, anti-infectives, haematinics, and health and nutrition. Themis Medicare is located in India.
Company Leadership PN
TD
MS
HM
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segments products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing,...
Company Leadership DK
KB
CD
Frequently Asked Questions Regarding Cipla Top Executives and Leadership Team
